Seed therapy for prostate cancer may zap fertility

NEW YORK (Reuters Health) - Radioactive "seeds" that are sometimes used to treat early prostate cancer may do widespread damage to the DNA in a man's sperm, a small study finds. The damage, researchers say, would seem to be enough to make a man infertile. And they should be aware of that going into treatment. Known as brachytherapy, the treatment involves implanting radiation-emitting pellets ...

IsoRay Applauds Cleveland Clinic Prostate Study Conclusions on Brachytherapy Superiority

IsoRay Inc. , a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, said today that the findings of a Cleveland Clinic study adds to the continuing evidence supporting the efficacy of brachytherapy.